Empagliflozin
SGLT2 Inhibitor · Type 2 Diabetes, Heart Failure, CKD
Drug Overview
- Active Ingredient
- Empagliflozin
- Brand Name
- Jardiance
- Drug Class
- SGLT2 Inhibitor
- Therapeutic Indication
- Type 2 Diabetes, Heart Failure, CKD
- Treats
- Type 2 Diabetes, Heart Failure & Chronic Kidney Disease
- Available Dosages
- 10mg, 25mg tablets
- Mechanism of Action
- SGLT2 inhibitor
- Pregnancy Category
- Category C / Not recommended 2nd/3rd trimester — fetal kidney risk
- Generic Available
- Yes
Warning & Precautions
Risk of ketoacidosis and volume depletion. Monitor renal function. Risk of urosepsis and Fournier's gangrene.
Clinical Identifiers
- RxNorm (RxCUI)
- 1545653
- NDC (National Drug Code)
- 0597-0150-30